請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/42336完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 陳為堅 | |
| dc.contributor.author | Sih-Syuan Huang | en |
| dc.contributor.author | 黃思瑄 | zh_TW |
| dc.date.accessioned | 2021-06-15T01:12:18Z | - |
| dc.date.available | 2014-09-16 | |
| dc.date.copyright | 2009-09-16 | |
| dc.date.issued | 2009 | |
| dc.date.submitted | 2009-07-30 | |
| dc.identifier.citation | Abecasis, G. R., Cherny, S. S., Cookson, W. O. & Cardon, L. R. (2002). Merlin--rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 30, 97-101.
Arai, M., Yamada, K., Toyota, T., Obata, N., Haga, S., Yoshida, Y., Nakamura, K., Minabe, Y., Ujike, H., Sora, I., Ikeda, K., Mori, N., Yoshikawa, T. & Itokawa, M. (2006). Association between polymorphisms in the promoter region of the sialyltransferase 8B (SIAT8B) gene and schizophrenia. Biol Psychiatry 59, 652-9. Berger, G. E., Smesny, S. & Amminger, G. P. (2006). Bioactive lipids in schizophrenia. Int Rev Psychiatry 18, 85-98. Berger, G. E., Wood, S. J., Pantelis, C., Velakoulis, D., Wellard, R. M. & McGorry, P. D. (2002). Implications of lipid biology for the pathogenesis of schizophrenia. Aust N Z J Psychiatry 36, 355-66. Bhat, A., Heath, S. C. & Ott, J. (1999). Heterogeneity for multiple disease loci in linkage analysis. Hum Hered 49, 229-31. Bosveld-van Haandel, L., Knegtering, R., Kluiter, H. & van den Bosch, R. J. (2006). Niacin skin flushing in schizophrenic and depressed patients and healthy controls. Psychiatry Res 143, 303-6. Bray, N. J. & Owen, M. J. (2001). Searching for schizophrenia genes. Trends Mol Med 7, 169-74. Bruses, J. L. & Rutishauser, U. (2001). Roles, regulation, and mechanism of polysialic acid function during neural development. Biochimie 83, 635-43. Chang, S. S., Liu, C. M., Lin, S. H., Hwu, H. G., Hwang, T. J., Liu, S. K., Hsieh, M. H., Guo, S. C. & Chen, W. J. (2009). Impaired flush response to niacin skin patch among schizophrenia patients and their nonpsychotic relatives: the effect of genetic loading. Schizophr Bull 35, 213-21. Chen, W. J., Liu, S. K., Chang, C. J., Lien, Y. J., Chang, Y. H. & Hwu, H. G. (1998). Sustained attention deficit and schizotypal personality features in nonpsychotic relatives of schizophrenic patients. Am J Psychiatry 155, 1214-20. Chiu, Y. F., Liang, K. Y. & Beaty, T. H. (2002). Multipoint linkage detection in the presence of heterogeneity. Biostatistics 3, 195-211. Eastwood, S. L. & Harrison, P. J. (2000). Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of complexin mRNAs. Mol Psychiatry 5, 425-32. Eastwood, S. L. & Harrison, P. J. (2005). Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons. Schizophr Res 73, 159-72. Faraone, S. V., Hwu, H. G., Liu, C. M., Chen, W. J., Tsuang, M. M., Liu, S. K., Shieh, M. H., Hwang, T. J., Ou-Yang, W. C., Chen, C. Y., Chen, C. C., Lin, J. J., Chou, F. H., Chueh, C. M., Liu, W. M., Hall, M. H., Su, J., Van Eerdewegh, P. & Tsuang, M. T. (2006). Genome scan of Han Chinese schizophrenia families from Taiwan: confirmation of linkage to 10q22.3. Am J Psychiatry 163, 1760-6. Fenton, W. S., Hibbeln, J. & Knable, M. (2000). Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia. Biol Psychiatry 47, 8-21. Fernandez-Novoa, L. & Cacabelos, R. (2001). Histamine function in brain disorders. Behav Brain Res 124, 213-33. Haas, H. L., Sergeeva, O. A. & Selbach, O. (2008). Histamine in the nervous system. Physiol Rev 88, 1183-241. Harrison, P. J. & Eastwood, S. L. (1998). Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia. Lancet 352, 1669-73. Harrison, P. J. & Weinberger, D. R. (2005). Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 10, 40-68; image 5. Hauser, E. R., Watanabe, R. M., Duren, W. L., Bass, M. P., Langefeld, C. D. & Boehnke, M. (2004). Ordered subset analysis in genetic linkage mapping of complex traits. Genet Epidemiol 27, 53-63. Hudson, C. J., Lin, A., Cogan, S., Cashman, F. & Warsh, J. J. (1997). The niacin challenge test: clinical manifestation of altered transmembrane signal transduction in schizophrenia? Biol Psychiatry 41, 507-13. Hwu, H. G., Faraone, S. V., Liu, C. M., Chen, W. J., Liu, S. K., Shieh, M. H., Hwang, T. J., Tsuang, M. M., OuYang, W. C., Chen, C. Y., Chen, C. C., Lin, J. J., Chou, F. H., Chueh, C. M., Liu, W. M., Hall, M. H. & Tsuang, M. T. (2005). Taiwan schizophrenia linkage study: the field study. Am J Med Genet B Neuropsychiatr Genet 134B, 30-6. Ito, C., Morisset, S., Krebs, M. O., Olie, J. P., Loo, H., Poirier, M. F., Lannfelt, L., Schwartz, J. C. & Arrang, J. M. (2000). Histamine H2 receptor gene variants: lack of association with schizophrenia. Mol Psychiatry 5, 159-64. Iwabuchi, K., Ito, C., Tashiro, M., Kato, M., Kano, M., Itoh, M., Iwata, R., Matsuoka, H., Sato, M. & Yanai, K. (2005). Histamine H1 receptors in schizophrenic patients measured by positron emission tomography. Eur Neuropsychopharmacol 15, 185-91. Junqueira, R., Cordeiro, Q., Meira-Lima, I., Gattaz, W. F. & Vallada, H. (2004). Allelic association analysis of phospholipase A2 genes with schizophrenia. Psychiatr Genet 14, 157-60. Kaminsky, R., Moriarty, T. M., Bodine, J., Wolf, D. E. & Davidson, M. (1990). Effect of famotidine on deficit symptoms of schizophrenia. Lancet 335, 1351-2. Kishi, T., Ikeda, M., Suzuki, T., Kitajima, T., Yamanouchi, Y., Kinoshita, Y., Ozaki, N. & Iwata, N. (2006). No association of complexin1 and complexin2 genes with schizophrenia in a Japanese population. Schizophr Res 82, 185-9. Knable, M. B., Barci, B. M., Webster, M. J., Meador-Woodruff, J. & Torrey, E. F. (2004). Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium. Mol Psychiatry 9, 609-20, 544. Lee, H. J., Song, J. Y., Kim, J. W., Jin, S. Y., Hong, M. S., Park, J. K., Chung, J. H., Shibata, H. & Fukumaki, Y. (2005). Association study of polymorphisms in synaptic vesicle-associated genes, SYN2 and CPLX2, with schizophrenia. Behav Brain Funct 1, 15. Lewis, D. A. & Levitt, P. (2002). Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci 25, 409-32. Lien, Y. J., Hsiao, P. C., Liu, C. M., Faraone, S. V., Tsuang, M. T., Hwu, H. G. & Chen, W. J. (2009a). Genetic linkage evidence for distinct subtypes of schizophrenia characterized by age at onset and neurocognitive deficits. Arch Gen Psychiatry (submitted). Lien, Y. J., Tsuang, H. C., Chiang, A., Liu, C. M., Hsieh, M. H., Hwang, T. J., Liu, S. K., Hsiao, P. C., Faraone, S. V., Tsuang, M. T., Hwu, H. G. & Chen, W. J. (2009b). The multidimensionality of schizotypy in nonpsychotic relatives of patients with schizophrenia and its applications in ordered subsets linkage analysis of schizophrenia. Am J Med Genet B Neuropsychiatr Genet. Lin, P. I., McInnis, M. G., Potash, J. B., Willour, V. L., Mackinnon, D. F., Miao, K., Depaulo, J. R. & Zandi, P. P. (2005). Assessment of the effect of age at onset on linkage to bipolar disorder: evidence on chromosomes 18p and 21q. Am J Hum Genet 77, 545-55. Lin, S. H., Liu, C. M., Chang, S. S., Hwu, H. G., Liu, S. K., Hwang, T. J., Hsieh, M. H., Guo, S. C. & Chen, W. J. (2007). Familial aggregation in skin flush response to niacin patch among schizophrenic patients and their nonpsychotic relatives. Schizophr Bull 33, 174-82. Liu, C. M., Chang, S. S., Liao, S. C., Hwang, T. J., Shieh, M. H., Liu, S. K., Chen, W. J. & Hwu, H. G. (2007). Absent response to niacin skin patch is specific to schizophrenia and independent of smoking. Psychiatry Res 152, 181-7. Mancama, D., Arranz, M. J., Munro, J., Osborne, S., Makoff, A., Collier, D. & Kerwin, R. (2002). Investigation of promoter variants of the histamine 1 and 2 receptors in schizophrenia and clozapine response. Neurosci Lett 333, 207-11. Messamore, E. (2003). Relationship between the niacin skin flush response and essential fatty acids in schizophrenia. Prostaglandins Leukot Essent Fatty Acids 69, 413-9. Messamore, E., Hoffman, W. F. & Janowsky, A. (2003). The niacin skin flush abnormality in schizophrenia: a quantitative dose-response study. Schizophr Res 62, 251-8. Morrow, J. D., Awad, J. A., Oates, J. A. & Roberts, L. J., 2nd (1992). Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans. J Invest Dermatol 98, 812-5. Morrow, J. D., Parsons, W. G., 3rd & Roberts, L. J., 2nd (1989). Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid. Prostaglandins 38, 263-74. Nadalin, S., Rubesa, G., Giacometti, J., Vulin, M., Tomljanovic, D., Vranekovic, J., Kapovic, M. & Buretic-Tomljanovic, A. (2008). BanI polymorphism of cytosolic phospholipase A2 gene is associated with age at onset in male patients with schizophrenia and schizoaffective disorder. Prostaglandins Leukot Essent Fatty Acids 78, 351-60. Nakai, T., Kitamura, N., Hashimoto, T., Kajimoto, Y., Nishino, N., Mita, T. & Tanaka, C. (1991). Decreased histamine H1 receptors in the frontal cortex of brains from patients with chronic schizophrenia. Biol Psychiatry 30, 349-56. Nakayama, J., Angata, K., Ong, E., Katsuyama, T. & Fukuda, M. (1998). Polysialic acid, a unique glycan that is developmentally regulated by two polysialyltransferases, PST and STX, in the central nervous system: from biosynthesis to function. Pathol Int 48, 665-77. Nurnberger, J. I., Jr., Blehar, M. C., Kaufmann, C. A., York-Cooler, C., Simpson, S. G., Harkavy-Friedman, J., Severe, J. B., Malaspina, D. & Reich, T. (1994). Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry 51, 849-59; discussion 863-4. Orange, P. R., Heath, P. R., Wright, S. R., Ramchand, C. N., Kolkeiwicz, L. & Pearson, R. C. (1996). Individuals with schizophrenia have an increased incidence of the H2R649G allele for the histamine H2 receptor gene. Mol Psychiatry 1, 466-9. Oyewumi, L. K., Vollick, D., Merskey, H. & Plumb, C. (1994). Famotidine as an adjunct treatment of resistant schizophrenia. J Psychiatry Neurosci 19, 145-50. Prell, G. D., Green, J. P., Kaufmann, C. A., Khandelwal, J. K., Morrishow, A. M., Kirch, D. G., Linnoila, M. & Wyatt, R. J. (1995). Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: their relationships to levels of other aminergic transmitters and ratings of symptoms. Schizophr Res 14, 93-104. Puri, B. K. & Singh, I. (2002). Normal phospholipid-related signal transduction in autism. Prog Neuropsychopharmacol Biol Psychiatry 26, 1405-7. Risch, N. (1988). A new statistical test for linkage heterogeneity. Am J Hum Genet 42, 353-64. Ross, B. M., Hughes, B., Turenne, S., Seeman, M. & Warsh, J. J. (2004). Reduced vasodilatory response to methylnicotinate in schizophrenia as assessed by laser Doppler flowmetry. Eur Neuropsychopharmacol 14, 191-7. Rosse, R. B., Kendrick, K., Fay-McCarthy, M., Prell, G. D., Rosenberg, P., Tsui, L. C., Wyatt, R. J. & Deutsch, S. I. (1996). An open-label study of the therapeutic efficacy of high-dose famotidine adjuvant pharmacotherapy in schizophrenia: preliminary evidence for treatment efficacy. Clin Neuropharmacol 19, 341-8. Sawada, K., Young, C. E., Barr, A. M., Longworth, K., Takahashi, S., Arango, V., Mann, J. J., Dwork, A. J., Falkai, P., Phillips, A. G. & Honer, W. G. (2002). Altered immunoreactivity of complexin protein in prefrontal cortex in severe mental illness. Mol Psychiatry 7, 484-92. Schaloske, R. H. & Dennis, E. A. (2006). The phospholipase A2 superfamily and its group numbering system. Biochim Biophys Acta 1761, 1246-59. Schmidt, S., Scott, W. K., Postel, E. A., Agarwal, A., Hauser, E. R., De La Paz, M. A., Gilbert, J. R., Weeks, D. E., Gorin, M. B., Haines, J. L. & Pericak-Vance, M. A. (2004). Ordered subset linkage analysis supports a susceptibility locus for age-related macular degeneration on chromosome 16p12. BMC Genet 5, 18. Shah, S. H., Kraus, W. E., Crossman, D. C., Granger, C. B., Haines, J. L., Jones, C. J., Mooser, V., Huang, L., Haynes, C., Dowdy, E., Vega, G. L., Grundy, S. M., Vance, J. M. & Hauser, E. R. (2006). Serum lipids in the GENECARD study of coronary artery disease identify quantitative trait loci and phenotypic subsets on chromosomes 3q and 5q. Ann Hum Genet 70, 738-48. Shah, S. H., Ramchand, C. N. & Peet, M. (1999). The niacin skin flush test: first-degree relatives show responses intermediate between patients and controls. Schizophr Res 36, 314. Shah, S. H., Vankar, G. K., Peet, M. & Ramchand, C. N. (2000). Unmedicated schizophrenic patients have a reduced skin flush in response to topical niacin. Schizophr Res 43, 163-4. Smesny, S., Berger, G., Rosburg, T., Riemann, S., Riehemann, S., McGorry, P. & Sauer, H. (2003). Potential use of the topical niacin skin test in early psychosis -- a combined approach using optical reflection spectroscopy and a descriptive rating scale. J Psychiatr Res 37, 237-47. Smesny, S., Rosburg, T., Klemm, S., Riemann, S., Baur, K., Rudolph, N., Grunwald, S. & Sauer, H. (2004). The influence of age and gender on niacin skin test results - implications for the use as a biochemical marker in schizophrenia. J Psychiatr Res 38, 537-43. Tao, R., Li, C., Zheng, Y., Qin, W., Zhang, J., Li, X., Xu, Y., Shi, Y. Y., Feng, G. & He, L. (2007). Positive association between SIAT8B and schizophrenia in the Chinese Han population. Schizophr Res 90, 108-14. Tavares, H., Yacubian, J., Talib, L. L., Barbosa, N. R. & Gattaz, W. F. (2003). Increased phospholipase A2 activity in schizophrenia with absent response to niacin. Schizophr Res 61, 1-6. Teare, M. D. & Barrett, J. H. (2005). Genetic epidemiology 2: genetic linkage studies. Lancet 366, 1036-44. Tokumaru, H., Umayahara, K., Pellegrini, L. L., Ishizuka, T., Saisu, H., Betz, H., Augustine, G. J. & Abe, T. (2001). SNARE complex oligomerization by synaphin/complexin is essential for synaptic vesicle exocytosis. Cell 104, 421-32. Tsuang, M. (2000). Schizophrenia: genes and environment. Biol Psychiatry 47, 210-20. van Os, J., Rutten, B. P. & Poulton, R. (2008). Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions. Schizophr Bull 34, 1066-82. Vazza, G., Bertolin, C., Scudellaro, E., Vettori, A., Boaretto, F., Rampinelli, S., De Sanctis, G., Perini, G., Peruzzi, P. & Mostacciuolo, M. L. (2007). Genome-wide scan supports the existence of a susceptibility locus for schizophrenia and bipolar disorder on chromosome 15q26. Mol Psychiatry 12, 87-93. Waldo, M. C. (1999). Co-distribution of sensory gating and impaired niacin flush response in the parents of schizophrenics. Schizophr Res 40, 49-53. Yu, Y., Tao, R., Shi, J., Zhang, X., Kou, C., Guo, Y., Lin, X., Liu, S., Ju, G., Xu, Q., Shang, H., Shen, Y. & Wei, J. (2005). A genetic study of two calcium-independent cytosolic PLA2 genes in schizophrenia. Prostaglandins Leukot Essent Fatty Acids 73, 351-4. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/42336 | - |
| dc.description.abstract | 背景：先前的文獻指出，精神分裂症患者對於菸鹼酸所引起的皮膚漲紅反應相較於健康對照組的強度較弱或是反應受損，並且此現象並未在其他精神疾患中發現，具有專一性。近期的研究也顯示精神分裂症患者對於菸鹼酸的受損的皮膚漲紅反應具有家族聚集性，且此現象在遺傳負荷較高的多發性家庭當中更為明顯。
目標：本研究的主要目的是以對於菸鹼酸的皮膚漲紅反應為基礎，利用排序子集之連鎖分析的方法進行精神分裂症的全基因掃瞄。 方法：Taiwan Schizophrenia Linkage Study為一個全國性的樣本，由兩個以上的家庭成員依據DSM-IV診斷具有精神分裂症或抑鬱型情感性分裂疾患的家庭所組成。基因定型包含369個平均間隔為9-cM的微衛星標記。其中至少一位家庭成員具有菸鹼酸皮膚貼片試驗資料的家庭共190個，作為本次分析的樣本。每個家庭皆計算其成員的平均菸鹼酸漲紅反應分數，並以此分數作為排序子集之連鎖分析的排序依據。排序子集之連鎖分析將家庭樣本依序放入連鎖分析以提高樣本的均質性，而取得各染色體當中由特定子集所產生的最大無母數連鎖分析Z值。以排列檢定對於子集所產生的連鎖訊號上升進行統計顯著的檢定。而連鎖訊號的全基因顯著程度則透過兩步驟的方式進行校正。 結果：菸鹼酸皮膚漲紅反應較正常的家庭所組成的子集，在5q35.2 (NPL-Z = 3.65, an increase of 2.97, empirical p = 0.006, nominal p = 0.00013)以及15q26 (NPL-Z = 3.08, an increase of 2.11, empirical p = 0.047, nominal p = 0.0011)位置的連鎖訊號上升達到統計顯著，並且達到全基因的統計顯著。而菸鹼酸皮膚漲紅反應較弱的家庭所組成的子集，在22q13.1 (NPL = 2.26, an increase of 2.09, empirical p = 0.043, nominal p = 0.012)位置的連鎖訊號上升達到統計顯著，但未達全基因的統計顯著。這些位置皆未曾出現在全基因掃瞄的顯著結果當中。 結論：本研究結果顯示菸鹼酸的漲紅反應可以作為精神分裂症潛在異質性的標誌變項，可用於精神分裂症次群組的區分，以利於找尋不同的易感受基因。 | zh_TW |
| dc.description.abstract | Objective: Previous studies suggested that the attenuation of flush response to topically applied niacin was specific to patients with schizophrenia, showed familial aggregation in families of patients with schizophrenia, and was more impaired in both patients and non-psychotic relatives from families with higher familial loading for schizophrenia. This study aimed to evaluate the linkage signal for schizophrenia in genome scan by means of ordered subset analysis on the basis of the impaired niacin flush response.
Methods: Subjects of this study were part of the participants of the Taiwan Schizophrenia Linkage Study, which collected a nation-wide family sample with at least two siblings fulfilling the DSM-IV criteria for schizophrenia or schizoaffective disorder, depressive type. The genotyping was conducted by the Center for Inherited Disease Research, with 369 microsatellite markers spaced at an average of 9-cM intervals. Among these families, 190 had at least one member with information on the niacin skin test and were included for this study. The mean niacin flush response score averaged over all the family members with the niacin skin test information was used as the covariate for each family. A series of ordered subset linkage analyses was then conducted to increase the homogeneity of the samples by ranking families according to the mean niacin flush response scores in each family, and generate a new maximum nonparametric linkage Z (NPL-Z) score on each chromosome for each subset of families. The statistical significance for a subset-derived increase in linkage signal was evaluated using permutations to obtain a chromosome-wide p value. Then the genome-wide significance level of the OSA linkage result was evaluated using a two-step correction procedure. Results: Two chromosomal regions were found to have significant increases in NPL-Z score by ranking families in descending order of niacin flush score, including 5q35.2 (NPL-Z = 3.65, an increase of 2.97, empirical p = 0.006) and 15q26 (NPL-Z = 3.08, an increase of 2.11, empirical p = 0.047). Both regions reached genome-wide significance level with a nominal p value of 0.00013 and 0.0011, respectively. Meanwhile, we also obtained a significant increase in linkage signal on chromosome 22q13.1 (NPL = 2.26, an increase of 2.09, empirical p = 0.043) by ranking families in ascending order of niacin flush score, through not reaching genome-wide significance (a nominal p value of 0.012). In contrast, there was little evidence of linkage on these regions in the original genome-wide analyses. Conclusions: These results suggest that the flush response to niacin may be a marker of underlying heterogeneity in schizophrenia and potentially useful to demarcate subgroups of the disorder with different susceptibility genes. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-15T01:12:18Z (GMT). No. of bitstreams: 1 ntu-98-R96842014-1.pdf: 583636 bytes, checksum: f273b8939644311055ddfc4453b962f2 (MD5) Previous issue date: 2009 | en |
| dc.description.tableofcontents | 摘要…… i
Abstract iii Content v List of Tables vi List of Figures vii List of Appendices viii Introduction 1 Methods 4 Participants 4 Interview Instruments and Diagnosis 5 Niacin Skin Patch Test 5 Genotyping 6 Data Analyses 7 Ordered Subset Linkage Analysis 7 Genome-wide Significance 8 Results 9 Sample Characteristics 9 Results of Ordered-Subset Analysis 9 Discussion 11 References 15 | |
| dc.language.iso | en | |
| dc.title | 利用菸鹼酸皮膚漲紅反應進行精神分裂症之排序子集的遺傳連鎖分析 | zh_TW |
| dc.title | Application of Niacin Skin Flush Response in Ordered-Subset Linkage Analysis of Schizophrenia | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 97-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 胡海國,郭柏秀 | |
| dc.subject.keyword | 精神分裂症,菸鹼酸皮膚漲紅反應,全基因掃瞄,子集排序之連鎖分析, | zh_TW |
| dc.subject.keyword | schizophrenia,niacin flush response,genome-wide analysis,ordered subset analysis, | en |
| dc.relation.page | 35 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2009-07-30 | |
| dc.contributor.author-college | 公共衛生學院 | zh_TW |
| dc.contributor.author-dept | 流行病學研究所 | zh_TW |
| 顯示於系所單位： | 流行病學與預防醫學研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-98-1.pdf 目前未授權公開取用 | 569.96 kB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。